Financials
Financial year 2025
PHARMACIE LUC MOREL from Mouscron, company number BE0448674587, closed financial year 2025 with a result of € -32,846 after tax. For that financial year PHARMACIE LUC MOREL recorded a gross margin of € 614,867 and equity of € 911,205. Compared with financial year 2024, the result moved from € 1,954 to € -32,846. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 17, 2026.
€ 911,205
▼ 3% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -32,846
▼ still € 1,954 profit in 2024
Profit after tax over the fiscal year.
€ 114,286
▲ 81% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 483,205.
People and assets in 2025
9.3
▲ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 609,347
▲ 4% vs 2024
€ 65,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 36,027
▼ 9% vs 2024
Of which on lease € 29,599.
Debts at end 2025
€ 438,394
▲ € 352,141 vs 2024
€ 53,350 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.
€ 324,736
▲ 29% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 143,920
▲ 25% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 596,869 | € 550,348 | € 601,042 | € 614,867 | ▲ 2% |
| Profit after taxes | € 89,074 | € -61,221 | € 1,954 | € -32,846 | ▼ € 34,801 |
| Equity | € 1,003,318 | € 942,097 | € 944,051 | € 911,205 | ▼ 3% |
| Total debts | € 572,932 | € 469,718 | € 455,580 | € 930,680 | ▲ 104% |
| Cash | € 173,084 | € 95,187 | € 63,298 | € 114,286 | ▲ 81% |
| Retained profit | € 575,318 | € 514,097 | € 516,051 | € 483,205 | ▼ 6% |
| Dividend | € 55,000 | € 0 | € 0 | € 0 | |
| Bank debt | € 65,207 | € 56,808 | € 86,254 | € 438,394 | ▲ € 352,141 |
| Balance sheet total | € 1,576,250 | € 1,411,815 | € 1,399,631 | € 1,841,885 | ▲ 32% |
| Employees (FTE) | 8.6 | 9.6 | 9.2 | 9.3 | ▲ 0.1 |
Key figures of PHARMACIE LUC MOREL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE LUC MOREL?
What happened at PHARMACIE LUC MOREL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 32,846 (▼ € 34,801 vs 2024). Source: NBB ↗
- DOMOSOPH SRL SRL became a director. NBB
- New establishment in Mouscron. KBO
- New establishment in Mouscron. KBO
- Start of the company according to the CBE. KBO
- SOTHI SA SA became a director. NBB
- LUCAGEST SA SA became a director. NBB
In short
From € 89,074 profit in 2022 to € 32,846 loss in 2025.
Paid € 36,566 in corporate taxes since 2022.
Best year ever: 2022, with € 89,074 profit.
On average € 66,100 of value added per employee in 2025.
A new publication or filing at PHARMACIE LUC MOREL? We notify you, reason included.
Follow PHARMACIE LUC MORELDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMACIE LUC MOREL are SOTHI SA SA, DOMOSOPH SRL SRL and LUCAGEST SA SA. The shares are held by LUCAGEST SA (89.8%) and Luc MOREL (10.2%).
Directors
According to the 2025 annual accounts
Director · represented by DUHEM Katelijn
since 1992
since 2016
Director · represented by MOREL Luc
since 1992
Shareholders
89.8%
Luc MOREL
10.2%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Sint-Legerstraat(D) 2
7711 Mouscron
Arthur Roelandtstraat(D) 2 box A
7711 Mouscron
Active since 12 November 1992
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0448.674.587
- VAT number
- BE 0448.674.587
- Registered office
- Sint-Legerstraat(D) 2, 7711 Mouscron
- Names & denominations
- PHARMACIE LUC MOREL
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 12 November 1992
- Peppol
- Active · Active since 12 Nov 2025
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten